文献速递母胎医学产科

重大胎儿先天性心脏病中的妊娠丢失:发生率、危险因素和发生时机

Pregnancy loss in major fetal congenital heart disease: incidence, risk factors and timing.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

该回顾性人群队列研究基于犹他州出生缺陷网络1997至2018年数据,纳入3120例重大胎儿先天性心脏病(CHD)病例,妊娠丢失发生率为5.3%,中位孕周27.3周。调整后总体CHD人群妊娠丢失风险为5.3%(95%CI 3.7-7.6%),孤立性CHD为1.4%(95%CI 0.9-2.3%),风险随CHD类型及是否合并其他胎儿诊断而异。

要点

  • 重大胎儿CHD总体妊娠丢失率为5.3%,孤立性CHD调整风险1.4%,均高于一般人群0.6%。
  • 二尖瓣狭窄、左心发育不良综合征等CHD类型妊娠丢失发生率较高。
  • 胎儿水肿、合并其他胎儿诊断、房室瓣反流≥中度及心室功能障碍与妊娠丢失相关。

核心结论

  • 重大胎儿CHD的妊娠丢失风险高于一般人群,且随CHD类型及是否合并其他胎儿诊断而变化。
  • 对CHD病例妊娠丢失发生率、危险因素和时机的深入理解应有助于患者咨询、产前监测和分娩计划。

研究设计与样本

  • 回顾性、人群水平队列研究,纳入犹他州出生缺陷网络(UBDN)1997至2018年诊断的重大CHD胎儿和婴儿。
  • 排除终止妊娠及轻微心血管诊断(如孤立性主动脉/肺动脉病变和孤立性间隔缺损)病例。
  • 从9351例心血管编码病例中识别3251例重大CHD,排除终止妊娠131例后研究队列为3120例。

主要发现

  • 活产2956例(94.7%),妊娠丢失164例(5.3%),妊娠丢失中位孕周27.3周。
  • 孤立性CHD 1848例(59.2%),合并其他胎儿诊断1272例(40.8%),其中遗传学诊断736例(57.9%)、心外畸形536例(42.1%)。
  • 妊娠丢失观察发生率最高见于二尖瓣狭窄(<13.5%)、左心发育不良综合征(HLHS)(10.7%)、右室双出口伴大血管关系正常或未特指(10.5%)及Ebstein畸形(9.9%)。
  • 总体CHD人群调整后妊娠丢失风险为5.3%(95%CI 3.7-7.6%),孤立性CHD为1.4%(95%CI 0.9-2.3%),基于一般人群风险0.6%的调整风险比分别为9.0(95%CI 6.0-13.0)和2.0(95%CI 1.0-6.0)。
  • 生存分析显示合并其他胎儿诊断者妊娠丢失生存曲线更陡,妊娠丢失率高于孤立性CHD(P < 0.0001)。

关键数值与推荐

  • 总体CHD人群多变量分析中与妊娠丢失相关的变量:女性胎儿性别(aOR 1.6,95%CI 1.1-2.3)、西班牙裔(aOR 1.6,95%CI 1.0-2.5)、水肿(aOR 6.7,95%CI 4.3-10.5)及合并其他胎儿诊断(aOR 6.3,95%CI 4.1-10)。
  • 产前诊断亚组多变量分析中与妊娠丢失相关的变量:母亲受教育年数(aOR 1.2,95%CI 1.0-1.4)、合并其他胎儿诊断(aOR 2.7,95%CI 1.4-5.6)、房室瓣反流≥中度(aOR 3.6,95%CI 1.3-8.8)及心室功能障碍(aOR 3.8,95%CI 1.2-11.1)。
  • 与妊娠丢失相关的诊断分组:HLHS及其变异型(aOR 3.0,95%CI 1.7-5.3)、其他单心室(aOR 2.4,95%CI 1.1-4.9)及其他(aOR 0.1,95%CI 0-0.97)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fetuses with congenital heart disease (CHD) are at increased risk of pregnancy loss compared with the general population. We aimed to assess the incidence, timing and risk factors of pregnancy loss in cases with major fetal CHD, overall and according to cardiac diagnosis. METHODS: This was a retrospective, population-level cohort study of fetuses and infants diagnosed with major CHD between 1997 and 2018 identified by the Utah Birth Defect Network (UBDN), excluding cases with termination of pregnancy and minor cardiovascular diagnoses (e.g. isolated aortic/pulmonary pathology and isolated septal defects). The incidence and timing of pregnancy loss were recorded, overall and according to CHD diagnosis, with further stratification based on presence of isolated CHD vs additional fetal diagnosis (genetic diagnosis and/or extracardiac malformation). Adjusted risk of pregnancy loss was calculated and risk factors were assessed using multivariable models for the overall cohort and prenatal diagnosis subgroup. RESULTS: Of 9351 UBDN cases with a cardiovascular code, 3251 cases with major CHD were identified, resulting in a study cohort of 3120 following exclusion of cases with pregnancy termination (n = 131). There were 2956 (94.7%) live births and 164 (5.3%) cases of pregnancy loss, which occurred at a median gestational age of 27.3 weeks. Of study cases, 1848 (59.2%) had isolated CHD and 1272 (40.8%) had an additional fetal diagnosis, including 736 (57.9%) with a genetic diagnosis and 536 (42.1%) with an extracardiac malformation. The observed incidence of pregnancy loss was highest in the presence of mitral stenosis (< 13.5%), hypoplastic left heart syndrome (HLHS) (10.7%), double-outlet right ventricle with normally related great vessels or not otherwise specified (10.5%) and Ebstein's anomaly (9.9%). The adjusted risk of pregnancy loss was 5.3% (95% CI, 3.7-7.6%) in the overall CHD population and 1.4% (95% CI, 0.9-2.3%) in cases with isolated CHD (adjusted risk ratio, 9.0 (95% CI, 6.0-13.0) and 2.0 (95% CI, 1.0-6.0), respectively, based on the general population risk of 0.6%). On multivariable analysis, variables associated with pregnancy loss in the overall CHD population included female fetal sex (adjusted odds ratio (aOR), 1.6 (95% CI, 1.1-2.3)), Hispanic ethnicity (aOR, 1.6 (95% CI, 1.0-2.5)), hydrops (aOR, 6.7 (95% CI, 4.3-10.5)) and additional fetal diagnosis (aOR, 6.3 (95% CI, 4.1-10)). On multivariable analysis of the prenatal diagnosis subgroup, years of maternal education (aOR, 1.2 (95% CI, 1.0-1.4)), presence of an additional fetal diagnosis (aOR, 2.7 (95% CI, 1.4-5.6)), atrioventricular valve regurgitation ≥ moderate (aOR, 3.6 (95% CI, 1.3-8.8)) and ventricular dysfunction (aOR, 3.8 (95% CI, 1.2-11.1)) were associated with pregnancy loss. Diagnostic groups associated with pregnancy loss were HLHS and variants (aOR, 3.0 (95% CI, 1.7-5.3)), other single ventricles (aOR, 2.4 (95% CI, 1.1-4.9)) and other (aOR, 0.1 (95% CI, 0-0.97)). Time-to-pregnancy-loss analysis demonstrated a steeper survival curve for cases with an additional fetal diagnosis, indicating a higher rate of pregnancy loss compared to cases with isolated CHD (P < 0.0001). CONCLUSIONS: The risk of pregnancy loss is higher in cases with major fetal CHD compared with the general population and varies according to CHD type and presence of additional fetal diagnoses. Improved understanding of the incidence, risk factors and timing of pregnancy loss in CHD cases should inform patient counseling, antenatal surveillance and delivery planning. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Jepson BM, Metz TD, Miller TA, et al. Pregnancy loss in major fetal congenital heart disease: incidence, risk factors and timing. Ultrasound Obstet Gynecol. 2023. PMID: 37099500. doi:10.1002/uog.26231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。